Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Ozempic's expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

is a medication approved by the Food and Drug Administration (FDA) to treat type 2 diabetes. Because Ozempic has been shown to boost weight loss in people with diabetes, it’s quickly become a ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Ozempic is primarily used for managing ... the same active ingredient found in Mounjaro. While Zepbound is FDA-approved for weight loss, Mounjaro is approved for managing type 2 diabetes.